These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 4732209)
21. Quality drugs and the Saskatchewan formulary. Johnson GE Can J Hosp Pharm; 1975; 28(3):84-6. PubMed ID: 10316621 [No Abstract] [Full Text] [Related]
22. Rationale drug therapy: reasons for failure and suggestions for its implementation. Mathur GP; Kushwaha KP; Mathur S Indian Pediatr; 1993 Jun; 30(6):815-8. PubMed ID: 7726879 [No Abstract] [Full Text] [Related]
23. Controlling the quality of Uncle Sam's drugs. Hecht A FDA Consum; 1977 May; 11(4):22-3. PubMed ID: 10316531 [No Abstract] [Full Text] [Related]
24. Impact of gatt agreement on drug prices. Pillai AM J Indian Med Assoc; 1995 Mar; 93(3):113, 120. PubMed ID: 8522810 [No Abstract] [Full Text] [Related]
25. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organ Tech Rep Ser; 2008; (948):1-138. PubMed ID: 18557474 [TBL] [Abstract][Full Text] [Related]
26. Engineering the therapies of tomorrow. Coghlan A New Sci; 1993 Apr; 138(1870):26-31. PubMed ID: 11656235 [No Abstract] [Full Text] [Related]
27. Assuring the quality of the nation's drugs. Interview by William E. Small. Michels D Am Pharm; 1980 Apr; NS20(4):40-2. PubMed ID: 7386377 [No Abstract] [Full Text] [Related]
28. In search of funding: the clinical investigator and the drug company; Commentary: why researchers need not be demoralized. Siris ES; Burrell CD IRB; 1983; 5(6):1-5. PubMed ID: 11649526 [No Abstract] [Full Text] [Related]
29. Perspectives on the FDA status of drug products manufactured by the recombinant DNA technique. Korwek EL; Trinker DS Food Drug Cosmet Law J; 1981 Oct; 36(10):517-35. PubMed ID: 11650658 [No Abstract] [Full Text] [Related]
30. Prescription drug prices in Canada. Gross D Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123 [No Abstract] [Full Text] [Related]
34. [Role of an association in promoting pharmaceutical quality assurance: transfer of know-how based on the buddy system]. Ba A; Courcambeck A; Degui H Med Trop (Mars); 2006 Dec; 66(6):538-41. PubMed ID: 17286016 [TBL] [Abstract][Full Text] [Related]
35. Roadmap for implementation of quality by design (QbD) for biotechnology products. Rathore AS Trends Biotechnol; 2009 Sep; 27(9):546-53. PubMed ID: 19647883 [TBL] [Abstract][Full Text] [Related]
36. [Quality of medicines in least developed countries]. Videau JY Med Trop (Mars); 2006 Dec; 66(6):533-7. PubMed ID: 17286015 [TBL] [Abstract][Full Text] [Related]
37. The morning-after pill: a well-kept secret. Hoffman J N Y Times Mag; 1993 Jan; ():12-15, 30, 32. PubMed ID: 11647458 [No Abstract] [Full Text] [Related]
38. [On the analytical results obtained with a controlled production according to the modern "standards of good manufacture"]. Mascellani G; Rocchi B Boll Chim Farm; 1971 Apr; 110(4):197-206. PubMed ID: 5111345 [No Abstract] [Full Text] [Related]
39. QUALITY CONTROL OF PHARMACEUTICALS. LEVI L; WALKER GC; PUGSLEY LI Can Med Assoc J; 1964 Oct; 91(15):781-5. PubMed ID: 14199105 [TBL] [Abstract][Full Text] [Related]
40. International Conference on Harmonisation; guidance on Q9 Quality Risk Management; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2006 Jun; 71(106):32105-6. PubMed ID: 16795933 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]